EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Serious illness conversations and quality of end-of-life care in patients with hematological malignancies—a retrospective quality improvement study

Cæcilie Borregaard Myrhøj, Rachelle Bernacki, Selma Bjerre-Bertelsen, Juliet Jacobsen, Jenny Klintman, Mary Jarden, Christoffer Johansen, Annika von Heymann, Stine Novrup Clemmensen

Supportive Care in Cancer · 2025

DOI: 10.1007/s00520-025-09855-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Supportive Care in Cancer, 2025. Verfasst von Cæcilie Borregaard Myrhøj und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark. caecilie.borregaard.myrhoej@regionh.dk. Hauptthemen laut MEDLINE: Hematologic Neoplasms, Terminal Care, Communication. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Patients with hematological malignancies frequently receive aggressive, poor-quality end-of-life care. In oncology, serious illness conversations conducted early in the illness trajectory, focusing on patients’ goals, values, and priorities, have been associated with improved end-of-life care and decreased symptoms of anxiety and depression. Yet, evidence of such supportive interventions’ impact in hematology remains limited. This study explores the association between receiving a serious illness conversation and the quality of end-of-life care and the timing of serious illness conversations in patients with hematological malignancies.

Methods

Single-center retrospective quality improvement study. Data on receipt of serious illness conversations and end-of-life care (hospitalizations, specialized palliative care referrals, place of death, receipt of anticancer treatment) were extracted from electronic healthcare records. Logistic regression, adjusted for sex, age, and diagnosis examined the differences between patients who did and did not receive a serious illness conversation. The study included patients with hematological malignancies, who died between 2020 and 2022 and received anticancer treatment within the last 12 months at a university hospital in Denmark.

Results

Among 311 patients (median age 74 years, 43% female), 63 (20%) received a serious illness conversation. Patients receiving conversations had significantly higher odds of referral to specialized palliative care (OR 2.67, 95% CI [1.44; 4.91]) and lower odds of receiving anticancer treatment within 30 days (OR 0.19, 95% CI [0.10; 0.37]) and 14 days (OR 0.21, 95% CI [0.09; 0.46) before death.

Conclusion

Serious illness conversations are associated with reduced aggressive end-of-life anticancer treatment and increased referrals to specialized palliative care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematologic NeoplasmsTerminal CareCommunicationHumansRetrospective StudiesFemaleMaleAgedMiddle AgedQuality ImprovementPalliative CareAged, 80 and overDenmarkAdult

Stichwörter der Autor:innen

Advance care planningCommunicationHematologyPalliative careRetrospective studiesTerminal care

Autor:innen und Institutionen

  • Department of Hematology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark. caecilie.borregaard.myrhoej@regionh.dk.
  • CASTLE - Cancer Survivorship and Treatment Late Effects Research Unit, Department of Oncology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark. caecilie.borregaard.myrhoej@regionh.dk.
  • Harvard Medical School, Boston, USA.
  • Department of Supportive Oncology, Dana Farber Cancer Institute, Boston, USA.
  • Palliative Care and Geriatric Medicine, Mass General Brigham, Boston, USA.
  • Department of Internal Medicine, Herlev and Gentofte Hospital, Copenhagen, Denmark.

Förderung

  • National Hospital

Zitieren

APA

Myrhøj, C. B., Bernacki, R., Bjerre-Bertelsen, S., Jacobsen, J., Klintman, J., Jarden, M., Johansen, C., von Heymann, A., & Clemmensen, S. N. (2025). Serious illness conversations and quality of end-of-life care in patients with hematological malignancies—a retrospective quality improvement study. Supportive Care in Cancer. https://doi.org/10.1007/s00520-025-09855-2

Vancouver

Myrhøj CB, Bernacki R, Bjerre-Bertelsen S, Jacobsen J, Klintman J, Jarden M, et al. Serious illness conversations and quality of end-of-life care in patients with hematological malignancies—a retrospective quality improvement study. Supportive Care in Cancer. 2025. doi:10.1007/s00520-025-09855-2

BibTeX
@article{Myrhj2025,
  author = {Myrhøj, Cæcilie Borregaard and Bernacki, Rachelle and Bjerre-Bertelsen, Selma and Jacobsen, Juliet and Klintman, Jenny and Jarden, Mary and Johansen, Christoffer and von Heymann, Annika and Clemmensen, Stine Novrup},
  title = {Serious illness conversations and quality of end-of-life care in patients with hematological malignancies—a retrospective quality improvement study},
  journal = {Supportive Care in Cancer},
  year = {2025},
  doi = {10.1007/s00520-025-09855-2}
}
Kostenlos starten →